Current Alzheimer Research
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 6
Author(s): Othman Ghribi*
Affiliation:
- School of Medicine and Health Sciences Room University of North Dakota Grand Forks, ND,United States
Export Options
About this article
Cite this article as:
Ghribi Othman*, Meet Our Editorial Board Member, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/156720501406170509185239
DOI https://dx.doi.org/10.2174/156720501406170509185239 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
18
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progestins for Symptomatic Endometriosis: Results of Clinical Studies
Current Drug Therapy Inhibition of GSK3 Dependent Tau Phosphorylation by Metals
Current Alzheimer Research Evidences of Brain Plasticity and Motor Control Modulation after Hemodialysis Session by Helixone Membrane: BOLD-fMRI Study
CNS & Neurological Disorders - Drug Targets Electrochemical Evaluation of an Outdated Antifungal Drug as Corrosion Inhibitor of Mild Steel in Neutral Chloride Media
Innovations in Corrosion and Materials Science (Discontinued) New Technologies: Non-Hormonal Female Contraception
Current Women`s Health Reviews Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells
Anti-Cancer Agents in Medicinal Chemistry Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands
Current Drug Targets - Inflammation & Allergy Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools
Protein & Peptide Letters Journal Current Genomics: News and Editorial Prospects
Current Genomics Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?
CNS & Neurological Disorders - Drug Targets Synaptic Correlates of Anterograde Amnesia and Intact Retrograde Memory in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Synthesis, Anticonvulsant and Neurotoxicity Evaluation of Some Newer N-(2-benzoylbenzofuran-3-yl)-3-(substituted)-propanamide Analogs
Central Nervous System Agents in Medicinal Chemistry COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact
Current Pharmaceutical Design MtDNA As a Cancer Marker: A Finally Closed Chapter?
Current Genomics Consequences of Secondary Hyperparathyroidism on Vascular Calcification and Cardiovascular Mortality: Potential Benefit of Calcimimetics
Current Drug Therapy Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases
Current Alzheimer Research Blood-brain Barrier Disruption Leads to Postoperative Cognitive Dysfunction
Current Neurovascular Research Synthesis and Antifungal Activity of Coumarins Derivatives Against Sporothrix spp.
Current Topics in Medicinal Chemistry Apathy Is not Associated with Performance in Brief Executive Tests in Patients with Mild Cognitive Impairment and Mild Alzheimers Disease
Current Alzheimer Research